Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRE0094 for Chronic Neuropathic Diabetic Foot Ulcers
NCT00312364Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2005
- Primary completion
- Dec 2007
- Countries
- 1
01
Overview
A Phase 2 trial of Sonedenoson in diabetic foot ulcer (DFU), sponsored by Pfizer. Started Dec 2005; status: completed.
02
Drugs
Sonedenoson
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00312364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312364.